Status:
COMPLETED
TElemedicine for NARcolepsy
Lead Sponsor:
Azienda Usl di Bologna
Collaborating Sponsors:
University of Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions:
Narcolepsy
Eligibility:
All Genders
14+ years
Phase:
NA
Brief Summary
The TENAR trial is the first randomized controlled trial (RCT) designed to evaluate the feasibility, efficacy, safety, and costs of a Telemedicine multidisciplinary approach for the management of narc...
Eligibility Criteria
Inclusion
- • Adolescents (≥14 years old) and adults with a diagnosis of narcolepsy according to ICSD-3 criteria at their first ("incident") or with established diagnosis ("prevalent" subjects), able to provide consent
Exclusion
- inability to read, write, or using a tablet;
- major psychiatric disorders.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT04316286
Start Date
April 1 2020
End Date
May 31 2023
Last Update
June 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Irccs - Istituto Delle Scienze Neurologiche
Bologna, Italy, 40139